Benjamin Shames

Title: Inventor Spotlight: Benjamin Shames

Introduction

Benjamin Shames is an innovative inventor based in Arlington, MA, who has made significant contributions in the field of medical technology. With a focus on improving diagnostic methods for hepatitis C virus (HCV), his work aims to enhance the understanding and treatment of this viral infection.

Latest Patents

Benjamin holds a patent for "Methods for amplifying hepatitis C virus nucleic acids." This method involves a two-stage PCR process to amplify a segment of a DNA template that is complementary to the genome of HCV RNA found in infected samples. The detailed process includes the use of specific outer and inner primers, with nucleotide sequences that ensure precise amplification of the HCV nucleic acids, facilitating more accurate diagnostics and research into the virus.

Career Highlights

Benjamin Shames is currently associated with Vertex Pharmaceuticals, Inc., a leading biotechnology company that focuses on innovative medicines for serious diseases. His role in the organization has allowed him to collaborate with some of the best minds in the industry, contributing to advancements in healthcare technology.

Collaborations

During his career, Benjamin has worked alongside notable colleagues, including Ann Dak-Yee Kwong and James Daniel Frantz. These collaborations have further enhanced his research and have contributed to the successful development of his patented methods.

Conclusion

Benjamin Shames is a dedicated inventor whose innovative methods for amplifying nucleic acids of the hepatitis C virus are paving the way for improved diagnostic techniques. His work at Vertex Pharmaceuticals, along with his collaborations, showcases the importance of teamwork in driving innovation in the healthcare industry.